Formulation and Evaluation of Taste-Masked Levocetirizine Dihydrochloride Orally Disintegrating Tablets

References

1. 1.↵
   1. Virely P.,
   2. Yarwood R.

   Zydis—A novel, fast dissolving dosage form. Manuf. Chem. 1999, 61 ( 2), 36– 37.

   OpenUrlGoogle Scholar
2. 2.↵
   1. Sastry S. V.,
   2. Nyshadham J. R.,
   3. Fix J. A.

   Recent technological advances in oral drug delivery—a review. Pharmaceutical Science & Technology Today 2000, 3 ( 4), 138– 145.

   OpenUrlPubMedGoogle Scholar
3. 3.↵
   1. Tillement J.,
   2. Testa B.,
   3. Bree F.

   Compared pharmacological characteristics in humans of racemic cetirizine and levocetirizine, two histamine H₁-receptor antagonists. Biochemical Pharmacology 2003, 66 ( 7), 1123– 1126.

   OpenUrlPubMedGoogle Scholar
4. 4.↵
   1. Simons E. R.,
   2. Gortiz S. S.,
   3. Simons K. J.

   Clinical pharmacology of levocetirizine, the active enantiomer of cetirizine, in children age 6–11 years. J. Allergy Clin. Immunology 2005, 115 ( 2), 355– 361.

   OpenUrlGoogle Scholar
5. 5.↵
   1. Dorfner K.

   Ion Exchanger Properties and Applications, 3rd edition. Ann Arbor Science Publishers, Inc,: Ann Arbor, MI, 1972; p. 2.

   Google Scholar
6. 6.↵
   1. Borodkin S.,
   2. Sunderberg D. P.

   Chewable tablets including coated particles of pseudoephedrine-weak cation exchange resin. Patent US 3,594,470, 1971.

   Google Scholar
7. 7.↵
   1. Sohi H.,
   2. Sultana Y.,
   3. Khar R. K.

   Taste Masking Technologies in Oral Pharmaceuticals: Recent Developments and Approaches. Drug Development and Industrial Pharmacy 2004, 30 ( 5), 429– 448.

   OpenUrlPubMedGoogle Scholar
8. 8.↵
   1. Choudhari P. D.,
   2. Colhe S. R.,
   3. Choudhari S. P.,
   4. More D. M.

   Use of ion-exchange resins to optimize the taste masking of bitter drug rizatriptan benjoate. Indian Drugs 2006, 43 ( 10).

   Google Scholar
9. 9.↵
   1. Matoba H.,
   2. Ohmori S.,
   3. Koyama H.,
   4. Kashihara T.

   Solid Preparation Comprising Ion Exchanger and Active Agent. US Patent 5,464,612, November 7, 1995.

   Google Scholar
10. 10.↵
    1. Agarwall R.,
    2. Mittal R.,
    3. Singh A.

    Studies of ion-exchange resin complex of chloroquine phosphate. Drug Dev. Ind. Pharm. 2000, 26 ( 7), 773– 776.

    OpenUrlPubMedGoogle Scholar
11. 11.↵
    1. Klancke J.

    Dissolution testing of orally disintegrating tablets. Dissolution Technologies 2003, 10 ( 2).

    Google Scholar
12. 12.↵
    1. Aly A.,
    2. Semreen M.,
    3. Qato M.

    Superdisintegrants for solid dispersion: To produce rapidly disintegrating tenoxicam tablets via camphor sublimation. Pharmaceutical Technology 2005, 29 ( 1), 68– 78.

    OpenUrlGoogle Scholar
13. 13.↵
    1. Nakamura T.,
    2. Tanigake A.,
    3. Miyananga Y.,
    4. Ogawa T.,
    5. Akiyoshi T.,
    6. Matsuyama K.,
    7. Uchida T.

    The effect of various substances on the suppression of the bitterness of quinine-human gustatory sensation, binding, and taste sensor studies. Chem. Pharm. Bull. 2002, 50 ( 12), 1589– 1593.

    OpenUrlPubMedGoogle Scholar
14. 14.↵
    Thermax Ion-Exchange resin, Information brochure.

    Google Scholar
15. 15.↵
    1. Nanda A.,
    2. Kandarapu R.,
    3. Garg S.

    An update on taste masking technologies for oral pharmaceuticals. Indian J. Pharm. Sci. 2002, 64 ( 1), 10– 17.

    OpenUrlGoogle Scholar
16. 16.↵
    1. Cotterill J. V.,
    2. Massie G.,
    3. Cowan D. P.

    Masking the taste of the conditioned taste aversion agent levamisole using an ion-exchange resin, for practical application in wildlife management. Pest Manag. Sci. 2006, 62 ( 2), 120– 125.

    OpenUrlPubMedGoogle Scholar
17. 17.↵
    Pharmaceutical technical bulletin, Poly plasdone XL-10, New Jersey, USA.

    Google Scholar